Mesa Laboratories Inc. has announced that Gary Owens will resign as President and CEO on April 12, 2026, allowing for a seamless transition in leadership. Owens has served as the company’s CEO since 2017 and led it through significant growth and market expansion.
The Board of Directors of the Lakewood-based firm has appointed Dr. Siddhartha Kadia as the new President and CEO, effective April 13, 2026. Dr. Kadia will also join the Board. John Sullivan, Chair of the Board, remarked on Kadia’s extensive experience in scaling life sciences businesses and emphasized his qualifications for leading Mesa’s next chapter.
Dr. Kadia previously served as CEO of Calibre Scientific and has held leadership roles at other companies in the life sciences sector. He holds a Ph.D. in Biomedical Engineering from Johns Hopkins University and has been involved with several public life sciences company boards.
In his statement, Dr. Kadia expressed his honor in joining Mesa at this crucial time and his commitment to building on the company’s strong foundation to deliver ongoing value to stakeholders.
The leadership transition is noteworthy as it may impact Mesa’s future direction and strategic initiatives in the life sciences industry. For more information, visit the company’s website.
The primary source was GlobeNewswire.
